Involving patients and patient advocates in clinical decision making, whether it be in choosing a treatment or in designing clinical trials, is extremely important, believes Joe O’Sullivan, MD, of Queen’s University Belfast, Belfast, UK. Prof. O’Sullivan speaks at the European Society for Medical Oncology (ESMO) 2018 Congress, in Munich, Germany, highlighting the importance of involving patients in clinical decision making.